At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Epidemiology of Cardiotoxicity in Children With Cancer
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Mar 16, 2016
In Brief
An observational study for Cardiovascular Diseases and 4 related conditions. Completed.
Detailed Summary
To provide a comprehensive analysis of risk factors for the development of clinical cardiotoxicities in over 6,000 children with cancer who had been treated on standardized protocols involving the use of anthracyclines alone or in combination with other potentially cardiotoxic therapies or with no use of anthracycline therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Heart Failure, Congestive, Death, Sudden, Cardiac, Heart Failure
Countries--
Collaborators--
Timeline
N/ACompletedFinished
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 1992
Study CompletionMar 1994
First PostedMay 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartApr 1, 1992
Study CompletionMar 1, 1994
TodayJul 2, 2026
Posted 26.1 years ago